Puma Biotechnology (PBYI) Capital Expenditures (2012 - 2025)
Puma Biotechnology (PBYI) posted Capital Expenditures of -$36,000 for Q4 2025, compared with $16,000 a year earlier.
Analysis
Puma Biotechnology (PBYI) Capital Expenditures (2012 - 2025) Analysis & Trends
For FY2025, Puma Biotechnology's Capital Expenditures came in at $71,000, up 26.8% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
- In prior years, Puma Biotechnology's Capital Expenditures was $56,000 in FY2024 (-60.0%) and $140,000 in FY2023.
- The Q4 2025 figure stands as the lowest quarterly Capital Expenditures since Q4 2018.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last four quarters, with an average decline of 15.1%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $26,000 (Q3 2025), $20,000 (Q2 2025) and $61,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Puma Biotechnology | 507.45 Mn | 120.09 Mn | 44.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Dec 31, 2018 | -380,000.00 |
| Sep 30, 2018 | 305,000.00 |
| Jun 30, 2018 | 205,000.00 |
| Mar 31, 2018 | 40,000.00 |
| Dec 31, 2017 | 145,000.00 |
| Sep 30, 2017 | 154,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Mar 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 557,000.00 |
API Access
Puma Biotechnology Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PBYI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();